Clinical Trials Browser

Phase 2 × Breast Neoplasms × Pemetrexed × Clear all

NCT03242616 2025-04-17

PemVin vs Vin in Previously Treated Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT02624700 2020-07-14

2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer

Phase 2 Terminated

13 enrolled 13 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00006007 2016-12-07

LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT02829008 2016-07-12

Low -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer Patients

Phase 2 Unknown

Breast Neoplasms

NCT00149214 2012-03-21

Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens

Phase 2 Completed

257 enrolled 15 charts

Breast Neoplasms

NCT00325234 2011-05-20

Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer

Phase 2 Completed

135 enrolled 19 charts

Breast Neoplasms

NCT00106002 2009-06-01

Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer

Phase 2 Completed

37 enrolled 9 charts

Breast Neoplasms, Breast Neoplasms, Male, Carcinoma, Ductal

NCT00063570 2009-05-29

Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy

Phase 2 Completed

73 enrolled 15 charts

Breast Neoplasms

NCT00072865 2007-01-26

Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT00191347 2007-01-26

A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms